|
CDCA5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.11022302462516E-16 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.78563888306871E-12 |
| Normal-vs-Stage2 |
1.964540E-03 |
| Normal-vs-Stage3 |
1.22230003896107E-09 |
| Normal-vs-Stage4 |
1.58860000043504E-07 |
| Stage1-vs-Stage2 |
5.606000E-01 |
| Stage1-vs-Stage3 |
1.890320E-02 |
| Stage1-vs-Stage4 |
6.353200E-04 |
| Stage2-vs-Stage3 |
4.153000E-01 |
| Stage2-vs-Stage4 |
1.300060E-02 |
| Stage3-vs-Stage4 |
2.681700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
4.444700E-04 |
| Normal-vs-Asian |
1.905380E-01 |
| Caucasian-vs-AfricanAmerican |
1.170960E-01 |
| Caucasian-vs-Asian |
5.061200E-01 |
| AfricanAmerican-vs-Asian |
3.878600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.32986979603811E-15 |
| Normal-vs-Female |
2.45049536218289E-11 |
| Male-vs-Female |
1.174200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.177570E-02 |
| Normal-vs-Age(41-60Yrs) |
1.64760427523447E-11 |
| Normal-vs-Age(61-80Yrs) |
1.81687997979907E-12 |
| Normal-vs-Age(81-100Yrs) |
2.178200E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.418800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.654400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.642450E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.540400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.010200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.506210E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.245000E-04 |
| Normal-vs-Grade 2 |
1.99962268965237E-12 |
| Normal-vs-Grade 3 |
3.79696274421804E-14 |
| Normal-vs-Grade 4 |
1.02989999994918E-06 |
| Grade 1-vs-Grade 2 |
3.847900E-02 |
| Grade 1-vs-Grade 3 |
1.592030E-04 |
| Grade 1-vs-Grade 4 |
1.156070E-04 |
| Grade 2-vs-Grade 3 |
3.337400E-03 |
| Grade 2-vs-Grade 4 |
5.578000E-04 |
| Grade 3-vs-Grade 4 |
5.660200E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.09880002266516E-09 |
| Normal-vs-ccB subtype |
2.74660294508067E-11 |
| ccA subtype-vs-ccB subtype |
4.20869999999685E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.35276251206551E-12 |
| Normal-vs-N1 |
1.987870E-04 |
| N0-vs-N1 |
7.413900E-04 |
|
|
